A 'Pink Tax' in Oncology? Evolent addresses a startling difference in what men and women pay for the same drug. Read Article
When Less is More in Radiation Oncology An Evolent program reduces unnecessary radiation treatments for breast cancer without compromising efficacy. Read Article
Designing the High-Value Oncology Practice Oncology Care Partners CEO Erich Mounce describes how his practices are purpose-built for value. Read Q&A
How to Talk to Family Members About Hospice and End-of-Life Care Evolent's Connie Ducaine writes in MarketWatch that patients need to be proactive to ensure their preferences for end of life are respected. Read External Article
Clinical Expertise When It Matters Most Our evidence-driven, patient-first model helps produce more informed decisions. Read Article
Connecting Our Businesses. Connecting Care. Our solutions are coming together under one brand to improve outcomes for people with complex health conditions. Read Article
Evolent Announces Focus on Specialty Care With Rebrand, Unification of Solutions Company's solutions are coming together to improve outcomes for people living with complex health conditions. Read Press Release
The Make-or-Break Moment for Payers in Specialty Care Our chief strategy officer speaks with Becker's about the largely untapped potential of value-based specialty care. Read Article
Bending the Oncology Cost Curve in 2023 and Beyond Our chief medical officer shares three trends likely to impact oncology drug spend in the near future. Read Article
